These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 32209723)

  • 1. 90 YEARS OF PROGESTERONE: Steroid receptors as MAPK signaling sensors in breast cancer: let the fates decide.
    Dwyer AR; Truong TH; Ostrander JH; Lange CA
    J Mol Endocrinol; 2020 Jul; 65(1):T35-T48. PubMed ID: 32209723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posttranslationally modified progesterone receptors direct ligand-specific expression of breast cancer stem cell-associated gene programs.
    Knutson TP; Truong TH; Ma S; Brady NJ; Sullivan ME; Raj G; Schwertfeger KL; Lange CA
    J Hematol Oncol; 2017 Apr; 10(1):89. PubMed ID: 28412963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoid receptors are required effectors of TGFβ1-induced p38 MAPK signaling to advanced cancer phenotypes in triple-negative breast cancer.
    Perez Kerkvliet C; Dwyer AR; Diep CH; Oakley RH; Liddle C; Cidlowski JA; Lange CA
    Breast Cancer Res; 2020 May; 22(1):39. PubMed ID: 32357907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integration of progesterone receptor mediated rapid signaling and nuclear actions in breast cancer cell models: role of mitogen-activated protein kinases and cell cycle regulators.
    Faivre E; Skildum A; Pierson-Mullany L; Lange CA
    Steroids; 2005; 70(5-7):418-26. PubMed ID: 15862825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stress sensing within the breast tumor microenvironment: how glucocorticoid receptors live in the moment.
    Kerkvliet CP; Truong TH; Ostrander JH; Lange CA
    Essays Biochem; 2021 Dec; 65(6):971-983. PubMed ID: 34132331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional hyperactivity of human progesterone receptors is coupled to their ligand-dependent down-regulation by mitogen-activated protein kinase-dependent phosphorylation of serine 294.
    Shen T; Horwitz KB; Lange CA
    Mol Cell Biol; 2001 Sep; 21(18):6122-31. PubMed ID: 11509655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modifications to glucocorticoid and progesterone receptors alter cell fate in breast cancer.
    Leehy KA; Regan Anderson TM; Daniel AR; Lange CA; Ostrander JH
    J Mol Endocrinol; 2016 Apr; 56(3):R99-R114. PubMed ID: 26831511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progesterone receptors induce cell cycle progression via activation of mitogen-activated protein kinases.
    Skildum A; Faivre E; Lange CA
    Mol Endocrinol; 2005 Feb; 19(2):327-39. PubMed ID: 15486045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of rapid signaling events with steroid hormone receptor action in breast and prostate cancer.
    Lange CA; Gioeli D; Hammes SR; Marker PC
    Annu Rev Physiol; 2007; 69():171-99. PubMed ID: 17037979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration of progesterone receptor action with rapid signaling events in breast cancer models.
    Lange CA
    J Steroid Biochem Mol Biol; 2008 Feb; 108(3-5):203-12. PubMed ID: 17964138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of action of the breast cancer-promoter hormone, 5α-dihydroprogesterone (5αP), involves plasma membrane-associated receptors and MAPK activation.
    Wiebe JP; Pawlak KJ; Kwok A
    J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt A):166-76. PubMed ID: 26519986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progesterone receptors act as sensors for mitogenic protein kinases in breast cancer models.
    Dressing GE; Hagan CR; Knutson TP; Daniel AR; Lange CA
    Endocr Relat Cancer; 2009 Jun; 16(2):351-61. PubMed ID: 19357196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
    Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
    Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-genomic signaling of steroid receptors in cancer.
    Thiebaut C; Vlaeminck-Guillem V; Trédan O; Poulard C; Le Romancer M
    Mol Cell Endocrinol; 2021 Dec; 538():111453. PubMed ID: 34520815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide crosstalk between steroid receptors in breast and prostate cancers.
    Paakinaho V; Palvimo JJ
    Endocr Relat Cancer; 2021 Jul; 28(9):R231-R250. PubMed ID: 34137734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor mechanisms mediating non-genomic actions of sex steroids.
    Boonyaratanakornkit V; Edwards DP
    Semin Reprod Med; 2007 May; 25(3):139-53. PubMed ID: 17447204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Making sense of cross-talk between steroid hormone receptors and intracellular signaling pathways: who will have the last word?
    Lange CA
    Mol Endocrinol; 2004 Feb; 18(2):269-78. PubMed ID: 14563938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroid receptor phosphorylation: Assigning function to site-specific phosphorylation.
    Ward RD; Weigel NL
    Biofactors; 2009; 35(6):528-36. PubMed ID: 19904813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome.
    Lange CA; Shen T; Horwitz KB
    Proc Natl Acad Sci U S A; 2000 Feb; 97(3):1032-7. PubMed ID: 10655479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progesterone receptor action: translating studies in breast cancer models to clinical insights.
    Lange CA; Sartorius CA; Abdel-Hafiz H; Spillman MA; Horwitz KB; Jacobsen BM
    Adv Exp Med Biol; 2008; 630():94-111. PubMed ID: 18637487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.